Graves' ophthalmopathy

From WikiMD's Medical Encyclopedia

Revision as of 01:57, 7 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Graves' ophthalmopathy
Synonyms Thyroid eye disease, Graves' orbitopathy
Pronounce N/A
Specialty N/A
Symptoms Exophthalmos, diplopia, eye irritation, lid retraction, periorbital edema
Complications Corneal ulcer, vision loss
Onset Typically 30-50 years old
Duration Months to years
Types N/A
Causes Autoimmune disorder associated with Graves' disease
Risks Smoking, radioiodine therapy
Diagnosis Clinical examination, imaging studies
Differential diagnosis Orbital cellulitis, pseudotumor, cavernous sinus thrombosis
Prevention N/A
Treatment Corticosteroids, radiotherapy, surgery
Medication Methimazole, propylthiouracil
Prognosis N/A
Frequency Affects 25-50% of people with Graves' disease
Deaths N/A


Graves' Ophthalmopathy[edit]

Patient exhibiting symptoms of Graves' ophthalmopathy, including bulging eyes.

Graves' ophthalmopathy, also known as thyroid eye disease (TED), is an autoimmune inflammatory disorder affecting the orbit and periorbital tissues. This condition is primarily associated with Graves' disease but can also occur in individuals with Hashimoto's thyroiditis or in those with normal thyroid function (euthyroid).

Characteristics[edit]

Graves' ophthalmopathy is characterized by:

  • Upper eyelid retraction
  • Lid lag, where the eyelid moves irregularly when the eyes move
  • Swelling and inflammation of eye tissues
  • Redness (erythema) and conjunctivitis
  • Bulging eyes (exophthalmos), caused by inflammation and swelling of the eye muscles and tissues

Association with Thyroid Disorders[edit]

This condition is most commonly seen in individuals with:

  • Graves' disease, an autoimmune disorder that leads to overactivity of the thyroid gland (hyperthyroidism).
  • Less commonly, it can be associated with Hashimoto's thyroiditis, an autoimmune condition causing underactive thyroid (hypothyroidism).
  • In some cases, it occurs in individuals with normal thyroid function (euthyroid).

Pathophysiology[edit]

The exact cause of Graves' ophthalmopathy is not fully understood, but it is believed to involve:

  • An autoimmune response where the body's immune system attacks the tissues around the eyes.
  • An interplay between environmental and genetic factors.

Symptoms and Signs[edit]

Symptoms of Graves' ophthalmopathy can include:

  • Dryness, irritation, and a gritty sensation in the eyes.
  • Sensitivity to light.
  • Blurred or double vision.
  • Difficulty moving the eyes.

Diagnosis[edit]

Diagnosis is typically based on:

  • Clinical examination of the eyes.
  • Medical history, particularly related to thyroid disease.
  • Imaging tests like CT scans or MRI to assess eye socket changes.

Treatment[edit]

Treatment of Graves' ophthalmopathy may involve:

  • Managing the underlying thyroid condition.
  • Corticosteroids to reduce inflammation.
  • Radiation therapy to the eye muscles.
  • Surgical intervention in severe cases to correct eye muscle and eyelid abnormalities.

Prognosis[edit]

The course of Graves' ophthalmopathy varies:

  • Some patients experience only mild symptoms.
  • In severe cases, it can lead to vision loss if not properly treated.

Prevention and Management[edit]

While prevention of the condition is not always possible, effective management of thyroid disorders can mitigate the severity of the symptoms.

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.